Identification and Characterization of Potential Drug Targets for SC5D

Target Name: SC5D

NCBI ID: G6309

SC5D

Identification and Characterization of Potential Drug Targets for SC5D

SC5D, short for solute carrier subfamily 5 member D, is a protein that is expressed in various tissues of the body, including the brain. It is a key regulator of intracellular signaling, specifically in the context of neurotransmitter signaling.SC5D has been identified as a potential drug target and is the focus of ongoing research at the Scripps Research Institute (SRI).

The solute carrier subfamily 5 member D (SC5D) is a transmembrane protein that is involved in the transport of a variety of molecules across the blood-brain barrier. It is a key regulator of intracellular signaling, specifically in the context of neurotransmitter signaling.SC5D has been identified as a potential drug target and is the focus of ongoing research at the Scripps Research Institute (SRI).

SC5D is a 12-kDa protein that is expressed in various tissues of the body, including the brain. It is a key regulator of intracellular signaling, specifically in the context of neurotransmitter signaling.SC5D has been identified as a potential drug target and is the focus of ongoing research at the Scripps Research Institute (SRI).

One of the key functions of SC5D is its role in the regulation of neurotransmitter release. Neurotransmitters are released from the axon terminal of neurons and are critical for communication between neurons and other cells in the nervous system. The release of neurotransmitters is regulated by a complex series of proteins, including SC5D.

SC5D has been shown to play a critical role in the regulation of neurotransmitter release from the axon terminal of neurons. It is expressed in the axon terminal of neurons and is involved in the regulation of the release of neurotransmitters such as dopamine, serotonin, and GABA.SC5D has been shown to play a critical role in the regulation of neurotransmitter release from the axon terminal of neurons. It is expressed in the axon terminal of neurons and is involved in the regulation of the release of neurotransmitters such as dopamine, serotonin, and GABA.

In addition to its role in neurotransmitter release, SC5D is also involved in the regulation of other intracellular signaling processes. For example, it has been shown to play a role in the regulation of ion channels, which are responsible for the flow of electrical current through the cell membrane.SC5D is also involved in the regulation of other intracellular signaling processes. For example, it has been shown to play a role in the regulation of ion channels, which are responsible for the flow of electrical current through the cell membrane.

The potential drug target status of SC5D is due to its unique structure and function. It is a transmembrane protein that is involved in the regulation of intracellular signaling, specifically in the context of neurotransmitter signaling.SC5D is a transmembrane protein that is involved in the regulation of intracellular signaling, specifically in the context of neurotransmitter signaling.

The ongoing research at the Scripps Research Institute (SRI) focuses on the identification and characterization of potential drug targets for SC5D. This includes studies to determine the mechanisms of action of drugs that have been shown to interact with SC5D and to identify new targets for further study. The potential drug targets for SC5D may include new neurotransmitters, ion channels, or other intracellular signaling molecules.

In conclusion, SC5D is a protein that is expressed in various tissues of the body and is involved in the regulation of intracellular signaling, specifically in the context of neurotransmitter signaling. It has been identified as a potential drug target and is the focus of ongoing research at the Scripps Research Institute (SRI). Further studies are needed to determine the mechanisms of action of potential drug targets

Protein Name: Sterol-C5-desaturase

Functions: Catalyzes a dehydrogenation to introduce C5-6 double bond into lathosterol in cholesterol biosynthesis

The "SC5D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SC5D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets